{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:27:47Z","timestamp":1790015267499,"version":"4.0.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,4]]},"DOI":"10.7759\/cureus.98430","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:13:28Z","timestamp":1764839608000},"source":"Crossref","is-referenced-by-count":1,"title":["Refractory Hypotension and Delayed Respiratory Failure in Amlodipine Toxicity: A Multimodal Management Approach"],"prefix":"10.7759","author":[{"given":"Maria","family":"Haq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chima","family":"Iloanugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabiu","family":"Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/18.suppl_a.71","article-title":"Pharmacological differences between calcium antagonists","volume":"18 Suppl A","author":"Opie LH","year":"1997","unstructured":"Opie LH. Pharmacological differences between calcium antagonists. Eur Heart J. 1997, 18 Suppl A:A71-9. 10.1093\/eurheartj\/18.suppl_a.71","journal-title":"Eur Heart J"},{"key":"ref2","article-title":"Calcium channel blocker toxicity","author":"Chakraborty RK","year":"2025","unstructured":"Chakraborty RK, Hamilton RJ. Calcium channel blocker toxicity. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.582471","article-title":"High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning","volume":"49","author":"Engebretsen KM","year":"2011","unstructured":"Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol (Phila). 2011, 49:277-83. 10.3109\/15563650.2011.582471","journal-title":"Clin Toxicol (Phila)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/546012","article-title":"Noncardiogenic pulmonary edema after amlodipine overdose without refractory hypotension and bradycardia","volume":"2015","author":"Hedaiaty M","year":"2015","unstructured":"Hedaiaty M, Eizadi-Mood N, Sabzghabaee AM. Noncardiogenic pulmonary edema after amlodipine overdose without refractory hypotension and bradycardia. Case Rep Emerg Med. 2015, 2015:546012. 10.1155\/2015\/546012","journal-title":"Case Rep Emerg Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.16258","article-title":"Calcium channel blocker overdose: not all the same toxicity","volume":"91","author":"Isbister GK","year":"2025","unstructured":"Isbister GK, Jenkins S, Harris K, Downes MA, Isoardi KZ. Calcium channel blocker overdose: not all the same toxicity. Br J Clin Pharmacol. 2025, 91:740-7. 10.1111\/bcp.16258","journal-title":"Br J Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36762","article-title":"Unique case of cardiogenic shock in the setting of cumulative calcium channel blocker toxicity","volume":"15","author":"Afzal MA","year":"2023","unstructured":"Afzal MA, Ozgur SS, Tagliaferri AR, Bathobakae L, Shamoon F. Unique case of cardiogenic shock in the setting of cumulative calcium channel blocker toxicity. Cureus. 2023, 15:e36762. 10.7759\/cureus.36762","journal-title":"Cureus"},{"key":"ref7","unstructured":"High-dose insulin euglycaemic therapy. (2024). Accessed. November 1, 2025: https:\/\/litfl.com\/high-dose-insulin-euglycaemic-therapy\/."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15642","article-title":"High-dose insulin should NOT be used without vasopressors in calcium channel blocker toxicity","volume":"89","author":"Rietjens SJ","year":"2023","unstructured":"Rietjens SJ, van Riemsdijk TE, Sikma MA, de Lange DW. High-dose insulin should NOT be used without vasopressors in calcium channel blocker toxicity. Br J Clin Pharmacol. 2023, 89:1275-8. 10.1111\/bcp.15642","journal-title":"Br J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2020.1725034","article-title":"The unknown known: non-cardiogenic pulmonary edema in amlodipine poisoning, a cohort study","volume":"58","author":"Lindeman E","year":"2020","unstructured":"Lindeman E, \u00c5lebring J, Johansson A, Ahlner J, Kugelberg FC, Nordmark Grass J. The unknown known: non-cardiogenic pulmonary edema in amlodipine poisoning, a cohort study. Clin Toxicol (Phila). 2020, 58:1042-9. 10.1080\/15563650.2020.1725034","journal-title":"Clin Toxicol (Phila)"},{"key":"ref10","article-title":"Evaluation of high-dose insulin\/euglycemia therapy for suspected \u03b2-blocker or calcium channel blocker overdose following guideline implementation","author":"Schult RF","year":"2022","unstructured":"Schult RF, Nacca N, Grannell TL, et al.. Evaluation of high-dose insulin\/euglycemia therapy for suspected \u03b2-blocker or calcium channel blocker overdose following guideline implementation. Am J Health-Syst Pharm. 2022, 547-55.","journal-title":"Am J Health-Syst Pharm"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2023.2268266","article-title":"Insulin concentrations following termination of high-dose insulin euglycemic therapy","volume":"61","author":"Wiener BG","year":"2023","unstructured":"Wiener BG, Smith CT, Patel S, Hoffman RS. Insulin concentrations following termination of high-dose insulin euglycemic therapy. Clin Toxicol (Phila). 2023, 61:697-701. 10.1080\/15563650.2023.2268266","journal-title":"Clin Toxicol (Phila)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-24906","article-title":"Hemoadsorption therapy for calcium channel blocker overdose at a tertiary-level intensive care unit: a retrospective study","volume":"29","author":"Omar S","year":"2025","unstructured":"Omar S, Shukla V, Khan AB, Dangor Z. Hemoadsorption therapy for calcium channel blocker overdose at a tertiary-level intensive care unit: a retrospective study. Indian J Crit Care Med. 2025, 29:130-6. 10.5005\/jp-journals-10071-24906","journal-title":"Indian J Crit Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437650-refractory-hypotension-and-delayed-respiratory-failure-in-amlodipine-toxicity-a-multimodal-management-approach","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:13:29Z","timestamp":1764839609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437650-refractory-hypotension-and-delayed-respiratory-failure-in-amlodipine-toxicity-a-multimodal-management-approach"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.98430","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,4]]}}}